Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Conditions
Neuroendocrine Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Study leads
Hong Zhao
Study Director
Cancer Institute and Hospital, Chinese Academy of Medical Sciences